Summary

Article Metadata

Pharmaceutical Giant's Sales Beat Estimates

This is a news story, published by Yahoo Finance, that relates primarily to Johnson & Johnson news.

drug discoveries news

For more drug discoveries news, you can click here:

more drug discoveries news

Yahoo Finance news

For more news from Yahoo Finance, you can click here:

more news from Yahoo Finance

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about

Strong Cancer Drug Sales

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest MedTech sales news, Cancer sales news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

Innovative Medicine sales

Benzinga

Benzinga

•

Health

Health

Johnson & Johnson Q1 Earnings: Strong Cancer Drug Sales, Boosts Quarterly Dividend, Anticipates Negative Currency Impact For 2025 Profit

Benzinga

Summary

Nutrition label

84% Informative

Johnson & Johnson reported sales of $21.89 billion , up 2.4% year over year and beating the consensus.

Innovative Medicine sales increased 2.3% or 4.2 operationally to $13.90 billion .

Cancer sales increased to $5.68 billion up 17.9% (+20.4 operational) Immunology sales fell to $3.71 billion , down 12.7% operational.

VR Score

85

Informative language

86

Neutral language

36

Article tone

formal

Language

English

Language complexity

50

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

7

https://s203.q4cdn.com/636242992/files/doc_financials/2025/q1/Final-JNJ-Earnings-Presentation-Q1-2025-Webcast.pdf https://www.benzinga.com/pressreleases/25/04/b44808099/johnson-johnson-reports-q1-2025-results?utm_campaign=partner_feed&utm_source=yahooFinance&utm_medium=partner_feed&utm_content=site&nid=44812561 https://s203.q4cdn.com/636242992/files/doc_financials/2025/q1/1Q25-Earnings-Press-Release-Final-Draft-4-14-with-Attachments.pdf https://www.benzinga.com/calendars/earnings?utm_campaign=partner_feed&utm_source=yahooFinance&utm_medium=partner_feed&utm_content=site&nid=44812561 https://www.benzinga.com/25/01/43125966/johnson-johnson-reports-q4-earnings-above-wall-street-estimates-driven-by-strong-cancer-drugs-revenue?utm_campaign=partner_feed&utm_source=yahooFinance&utm_medium=partner_feed&utm_content=site&nid=44812561 https://www.benzinga.com/25/04/44737545/johnson-johnson-protagonist-partnered-investigational-psoriasis-oral-pill-shows-75-of-adolescents-achieved-completely-clear-skin?utm_campaign=partner_feed&utm_source=yahooFinance&utm_medium=partner_feed&utm_content=site&nid=44812561 https://www.benzinga.com/25/04/44806571/johnson-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts?utm_campaign=partner_feed&utm_source=yahooFinance&utm_medium=partner_feed&utm_content=site&nid=44812561

Source diversity

2

s203.q4cdn.com www.benzinga.com

Affiliate links

no affiliate links

Read full article

Small business owner?

Otherweb launches Autoblogger—a revolutionary way to bring more leads to any small business, using the power of AI.

Powered by Otherweb